Clinical Endocrinology 2005: Vol 63 Index

2005·3.8 MB·English

Clinical Endocrinology (2005) 63, 704—712 doi: 10.1111/j.1365-2265.2005.02426.x
index
Acosta, M. see Iglesias, P. Berioli, M.G. see Celi, F.
Agosti, B. see Cappelli, C. Besser, G.M. see Chung, T.T.
Akalin, S. see Yavuz, D. Betterle, C. see De Bellis, A.
Akgul, E.O. see Ozcan, O. Beyhan, Z. see Ozcan, O.
Akre, O. see Berinder, K. Biber, F.Z. see Darcan, S.
Alexiadis, M. see Fuller, P.J. Bilgi, C. see Ozcan, O.
Allemann, S. see Trepp, R. Bindi, G. see Stagi, S.
Al-Qahtani, A., Muttukrishna, S., Appasamy, M., Johns, J., Cranfield, Bini, V. see Celi, F.
M., Visser, J.A., Themmen, A.P.N. and Groome, N.P. Develop- Biswas, M., Smith, J., Jadon, D., McEwan, P., Rees, D.A., Evans, L.M.,
ment of a sensitive enzyme immunoassay for anti-Miillerian Scanlon, M.F. and Davies, J.S. Long-term remission following
hormone and the evaluation of potential clinical applications withdrawal of dopamine agonist therapy in subjects with
in males and females, 267 microprolactinomas, 26
Ambrosio, M.R. see Tita, P. Bizzarro, A. see De Bellis, A.
Ammini, A.C. see Turton, J.P.G. Bobbert, T. see Mai, K.
Andria, G. see Melis, D. Bobbert, T., Brechtel, L., Mai, K., Otto, B., Maser-Gluth, C., Pfeiffer,
Appasamy, M. see Al-Qahtani, A. A.F.H., Spranger, J. and Diederich, S$. Adaptation of the hypoth-
Arwert, L.I., Roos, J.C., Lips, P., Twisk, J.W.R., Manoliu, R.A. and alamic-pituitary hormones during intensive endurance train-
Drent, M.L. Effects of 10 years of growth hormone (GH) ing, 530
replacement therapy in adult GH-deficient men, 310 Boerlin, V. see van der Hoek, J.
Asano, A. see Liang, H. Bogazzi, F., Russo, D., Locci, M.T., Chifenti, B., Ultimieri, F., Raggi,
Atkinson, A.B., Kennedy, A., Wiggam, M.I., McCance, D.R. and F., Cosci, C., Sardella, C., Costa, A., Gasperi, M., Bartalena, L.
Sheridan, B. Long-term remission rates after pituitary surgery and Martino, E. Apoptosis is reduced in the colonic mucosa of
for Cushing’s disease: the need for long-term surveillance, 549 patients with acromegaly, 683
Auriemma, R.S. see Colao, A. Bolund, L. see Siggaard, C.
Auriemma, R.S. see Vitale, G. Bona, G. see Camilot, M.
Aversa, A. see Isidori, A.M. Bondanelli, M. see Tita, P.
Aydin, T., Karacan, I., Demir, S.E. and Sahin, Z. Bone loss in males with Bonifacio, V. see Isidori, A.M.
ankylosing spondylitis: its relation to sex hormone levels, 467 Bouloux, P.M. see Turton, J.P.G.
Baek, K.H. see Oh, K.W. Bowers, C.Y. see Soares-Welch, C.
Bahr, V. see Mai, K. Bravata, D.M. see Liu, H.
Baik, S.H. see Kim, S.M. Brechtel, L. see Bobbert, T.
Baldazzi, L. see Nicoletti, A. Bremner, A.P. see Walsh, J.P.
Baldeschi, L. see Wakelkamp, I.M.M.J. Brierley, J., Tsang, R., Panzarella, T. and Bana, N. Prognostic factors
Balsamo, A. see Nicoletti, A. and the effect of treatment with radioactive iodine and external
Bana, N. see Brierley, J. beam radiation on patients with differentiated thyroid cancer
Barbaro, D., Simi, U., Meucci, G., Lapi, P., Orsini, P. and Pasquini, seen at a single institution over 40 years, 418
C. Thyroid papillary cancers: microcarcinoma and carcinoma, Briganti, F. see Colao, A.
incidental cancers and non-incidental cancers — are they differ- Brismar, K. see Undén, A.-L.
ent diseases?, 577 Broch, M. see Gonzalez-Clemente, J.M.
Barbieri, M. see Rizzo, M.R. Broch, M. see Vilarrasa, N.
Barp, L. see Nicoletti, A. Bronstein, M., Musolino, N., Jallad, R., Cendros, J.M., Ramis, J.,
Barreca, A. see Resmini, E. Obach, R., Leselbaum, A. and Catus, F. Pharmacokinetic profile
Barrett, P.H.R. see Ng, T.W.K. of lanreotide Autogel in patients with acromegaly after four
Bartalena, L. see Bogazzi, F. deep subcutaneous injections of 60, 90 or 120 mg every 28 days,
Baxter, R.C. see Nelson, A.E. 514
Beck-Peccoz, P. see Morpurgo, P.S. Bronstein, M.D. see Jallad, R.S.
Bellastella, A. see De Bellis, A. Bulsara, M.K. see Walsh, J.P.
Belloni, D.R. see Kinlaw, W.B. Burlina, A.B. see Melis, D.
Benigno, V. see Melis, D. Cabaccan, J. see Liu, H.
Berinder, K., Stackenis, I., Akre, O., Hirschberg, A.L. and Hulting, Cacciari, E. see Nicoletti, A.
A.-L. Hyperprolactinaemia in 271 women: up to three decades Caglieresi, C. see Canale, D.
of clinical follow-up, 450 Caixas, A. see Gonzalez-Clemente, J.M.
704 © 2005 Blackwell Publishing Ltd
Clinical Endocrinology (2005) 63, 704—712 doi: 10.1111/j.1365-2265.2005.02426.x
index
Acosta, M. see Iglesias, P. Berioli, M.G. see Celi, F.
Agosti, B. see Cappelli, C. Besser, G.M. see Chung, T.T.
Akalin, S. see Yavuz, D. Betterle, C. see De Bellis, A.
Akgul, E.O. see Ozcan, O. Beyhan, Z. see Ozcan, O.
Akre, O. see Berinder, K. Biber, F.Z. see Darcan, S.
Alexiadis, M. see Fuller, P.J. Bilgi, C. see Ozcan, O.
Allemann, S. see Trepp, R. Bindi, G. see Stagi, S.
Al-Qahtani, A., Muttukrishna, S., Appasamy, M., Johns, J., Cranfield, Bini, V. see Celi, F.
M., Visser, J.A., Themmen, A.P.N. and Groome, N.P. Develop- Biswas, M., Smith, J., Jadon, D., McEwan, P., Rees, D.A., Evans, L.M.,
ment of a sensitive enzyme immunoassay for anti-Miillerian Scanlon, M.F. and Davies, J.S. Long-term remission following
hormone and the evaluation of potential clinical applications withdrawal of dopamine agonist therapy in subjects with
in males and females, 267 microprolactinomas, 26
Ambrosio, M.R. see Tita, P. Bizzarro, A. see De Bellis, A.
Ammini, A.C. see Turton, J.P.G. Bobbert, T. see Mai, K.
Andria, G. see Melis, D. Bobbert, T., Brechtel, L., Mai, K., Otto, B., Maser-Gluth, C., Pfeiffer,
Appasamy, M. see Al-Qahtani, A. A.F.H., Spranger, J. and Diederich, S$. Adaptation of the hypoth-
Arwert, L.I., Roos, J.C., Lips, P., Twisk, J.W.R., Manoliu, R.A. and alamic-pituitary hormones during intensive endurance train-
Drent, M.L. Effects of 10 years of growth hormone (GH) ing, 530
replacement therapy in adult GH-deficient men, 310 Boerlin, V. see van der Hoek, J.
Asano, A. see Liang, H. Bogazzi, F., Russo, D., Locci, M.T., Chifenti, B., Ultimieri, F., Raggi,
Atkinson, A.B., Kennedy, A., Wiggam, M.I., McCance, D.R. and F., Cosci, C., Sardella, C., Costa, A., Gasperi, M., Bartalena, L.
Sheridan, B. Long-term remission rates after pituitary surgery and Martino, E. Apoptosis is reduced in the colonic mucosa of
for Cushing’s disease: the need for long-term surveillance, 549 patients with acromegaly, 683
Auriemma, R.S. see Colao, A. Bolund, L. see Siggaard, C.
Auriemma, R.S. see Vitale, G. Bona, G. see Camilot, M.
Aversa, A. see Isidori, A.M. Bondanelli, M. see Tita, P.
Aydin, T., Karacan, I., Demir, S.E. and Sahin, Z. Bone loss in males with Bonifacio, V. see Isidori, A.M.
ankylosing spondylitis: its relation to sex hormone levels, 467 Bouloux, P.M. see Turton, J.P.G.
Baek, K.H. see Oh, K.W. Bowers, C.Y. see Soares-Welch, C.
Bahr, V. see Mai, K. Bravata, D.M. see Liu, H.
Baik, S.H. see Kim, S.M. Brechtel, L. see Bobbert, T.
Baldazzi, L. see Nicoletti, A. Bremner, A.P. see Walsh, J.P.
Baldeschi, L. see Wakelkamp, I.M.M.J. Brierley, J., Tsang, R., Panzarella, T. and Bana, N. Prognostic factors
Balsamo, A. see Nicoletti, A. and the effect of treatment with radioactive iodine and external
Bana, N. see Brierley, J. beam radiation on patients with differentiated thyroid cancer
Barbaro, D., Simi, U., Meucci, G., Lapi, P., Orsini, P. and Pasquini, seen at a single institution over 40 years, 418
C. Thyroid papillary cancers: microcarcinoma and carcinoma, Briganti, F. see Colao, A.
incidental cancers and non-incidental cancers — are they differ- Brismar, K. see Undén, A.-L.
ent diseases?, 577 Broch, M. see Gonzalez-Clemente, J.M.
Barbieri, M. see Rizzo, M.R. Broch, M. see Vilarrasa, N.
Barp, L. see Nicoletti, A. Bronstein, M., Musolino, N., Jallad, R., Cendros, J.M., Ramis, J.,
Barreca, A. see Resmini, E. Obach, R., Leselbaum, A. and Catus, F. Pharmacokinetic profile
Barrett, P.H.R. see Ng, T.W.K. of lanreotide Autogel in patients with acromegaly after four
Bartalena, L. see Bogazzi, F. deep subcutaneous injections of 60, 90 or 120 mg every 28 days,
Baxter, R.C. see Nelson, A.E. 514
Beck-Peccoz, P. see Morpurgo, P.S. Bronstein, M.D. see Jallad, R.S.
Bellastella, A. see De Bellis, A. Bulsara, M.K. see Walsh, J.P.
Belloni, D.R. see Kinlaw, W.B. Burlina, A.B. see Melis, D.
Benigno, V. see Melis, D. Cabaccan, J. see Liu, H.
Berinder, K., Stackenis, I., Akre, O., Hirschberg, A.L. and Hulting, Cacciari, E. see Nicoletti, A.
A.-L. Hyperprolactinaemia in 271 women: up to three decades Caglieresi, C. see Canale, D.
of clinical follow-up, 450 Caixas, A. see Gonzalez-Clemente, J.M.
704 © 2005 Blackwell Publishing Ltd
Author Index
Cakir, E. see Ozcan, O. Chung, U.-I. see Lee, S.
Camilot, M., Teofoli, F., Gandini, A., Franceschi, R., Rapa, A., Cor- Cicognani, A. see Nicoletti, A.
rias, A., Bona, G., Radetti, G. and Tato, L. Thyrotropin receptor Cochran, E. see Musso, C.
gene mutations and TSH resistance: variable expressivity in the Coker, M. see Darcan, S$.
heterozygotes, 146 Colao, A. see Palomba, S.
Canale, D., Caglieresi, C., Moschini, C., Liberati, C.D., Macchia, E., Colao, A. see Vitale, G.
Pinchera, A. and Martino, E. Androgen receptor polymorphism Colao, A., Pivonello, R., Cappabianca, P., Briganti, E, Tortora, F,,
(CAG repeats) and androgenicity. 9 v3e5 6 Auriemma, R.S., De Martino, M.C., Marzullo, P. and Lombardi, G.
Capanna, R. see Mohn, A. Effect of gender and gonadal status on the long-term response
Cappabianca, P. see Colao, A. to somatostatin analogue treatment in acromegaly, 342
Cappelli, C., Pirola, I., Cumetti, D., Micheletti, L., Tironi, A., Gan- Cole, D. see Soule, S.
dossi, E., De Martino, E., Cherubini, L., Agosti, B., Castellano, Cole, T.J. see Mehta, A.
M., Mattanza, C. and Rosei, E.A. Is the anteroposterior and Conaglen, J.V. see Learoyd, D.L.
transverse diameter ratio of nonpalpable thyroid nodules a Conte, M. see De Bellis, A.
sonographic criteria for recommending fine-needle aspiration Copinschi, G. see Leproult, R.
cytology?, 689 Coronella, C. see De Bellis, A.
Cappiello, V. see Morpurgo, P.S. Corrias, A. see Camilot, M.
Carta, A. see Tita, P. Corydon, T.J. see Siggaard, C.
Casa, R.D. see Melis, D. Cosci, C. see Bogazzi, F.
Cassar, J. see Turton, J.P.G. Costa, A. see Bogazzi, F.
Castellano, M. see Cappelli, C. Cranfield, M. see Al-Qahtani, A.
Caterina, G. see Palomba, S. Crown, A. and Lightman, S. Why is the management of glucocorti-
Catus, F. see Bronstein, M. coid deficiency still controversial: a review of the literature, 483
Celi, F., Bini, V., Papi, F., Santilli, E., Ferretti, A., Mencacci, M., Cumetti, D. see Cappelli, C.
Berioli, M.G., De Giorgi, G. and Falorni, A. Circulating acylated D’ Andrea, F. see Rizzo, M.R.
and total ghrelin and galanin in children with insulin-treated Daniels, G.H. see Kinlaw, W.B.
type 1 diabetes: relationship to insulin therapy, metabolic con- Darcan, $., Unak, P., Yalman, O., Lambrecht, EY., Biber, EZ., Gdksen, D.
trol and pubertal development, 139 and Coker, M. Determination of iodine concentration in urine
Cendros, J.M. see Bronstein, M. by isotope dilution analysis and thyroid volume of school children
Chan, D.C.F. see Ng, T.W.K. in the west coast of Turkey after mandatory salt iodization, 543
Chan, I.H.S. see Ng, P.C. Dattani, M.T. see Mehta, A.
Channer, K.S. see Kapoor, D. Dattani, M.T. see Turton, J.P.G.
Chen, Y.-J. see Liu, R.-T. Dattani, M.T. Growth hormone deficiency and combined pituitary
Cheng, J.-T. see Liu, R.-T. hormone deficiency: does the genotype matter?, 121
Cherubini, L. see Cappelli, C. Davies, J.H., Evans, B.A.J., Jenney, M.E.M. and Gregory, J.W. Skeletal
Chew, S.L. see Chung, T.T. morbidity in childhood acute lymphoblastic leukaemia, |
Chiarelli, F. see Mohn, A. Davies, J.S. see Biswas, M.
Chiarelli, F. see Stagi, S. De Bellis, A., Bizzarro, A., Perrino, S., Coronella, C., Conte, M.,
Chifenti, B. see Bogazzi, F. Pasquali, D., Sinisi, A.A., Betterle, C. and Bellastella, A. Char-
Ching, H.L. see Ng, T.W.K. acterization of antipituitary antibodies targeting pituitary
Cho, Y.M. see Kim, TY. hormone-secreting cells in idiopathic growth hormone defi-
Choi, D.S. see Kim, S.M. ciency and autoimmune endocrine diseases, 45
Choi, K.M. see Kim, S.M. De Giorgi, G. see Celi, F.
Choi, M.G. see Oh, K.W. De Martino, E. see Cappelli, C.
Chong, K. see Turton, J.P.G. De Martino, M.C. see Colao, A.
Chou, E.-F. see Liu, R.-T. Deeb, A., Mason, C., Lee, Y.S. and Hughes, I.A. Correlation between
Christ, E.R. see Trepp, R. genotype, phenotype and sex of rearing in 111 patients with
Christensen, J.H. see Siggaard, C. partial androgen insensitivity syndrome, 56
Christiansen, P. see Moosgaard, B. Deeg, D.J.H. see Puts, M.T.E.
Chrousos, G.P. and Kaltsas, G. Post-SARS sickness syndrome Delbridge, L.W. see Learoyd, D.L.
manifestations and endocrinopathy: how, why, and so what?, Demir, S.E. see Aydin, T.
363 Di Marzio D. see Mohn, A.
Chung, T.T., Drake, W.M., Evanson, J., Walker, D., Plowman, P.N., Di Rocco, M. see Melis, D.
Chew, S.L., Grossman, A.B., Besser, G.M. and Monson, J.P. Diederich, S. see Bobbert, T.
Tumour surveillance imaging in patients with extrapituitary Diederich, S. see Mai, K.
tumours receiving growth hormone replacement, 274 Diez, J.J. see Iglesias, P.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704-712
706 Author Index
Donati, A. see Melis, D. Giménez-Pérez, G. see Gonzalez-Clemente, J.M.
Doyle, M.E. see Hardin, D.S. Giménez-Palop, O. see Gonzalez-Clemente, J.M.
Drake, W.M. see Chung, T.T. Giusti, M. see Resmini, E.
Drent, M.L. see Arwert, L.I. Gong, G. see Kim, T-Y.
Drop, S.L.S. see Mul, D. Gonzalez-Clemente, J.M., Mauricio, D., Richart, C., Broch, M.,
Dudczak, R. see Karanikas, G. Caixas, A., Megia, A., Giménez-Palop, O., Simon, I., Martinez-
Dunger, D.B. see Yuen, K.C.J. Riquelme, A., Giménez-Pérez, G. and Vendrell, J. Diabetic neu-
Dwivedi, M. see Sinha, S. ropathy is associated with activation of the TNF-a system in
Egle, U.T. see Kahaly, G.J. subjects with type 1 diabetes mellitus, 525
Elofsson, S. see Undén, A.-L. Gooren, L.J.G. see Schaap, L.A.
Elston, M.S. see Learoyd, D.L. Gorden, P. see Musso, C.
Engelmann, M.D. see Ogard, C.G. Gosnell, J. see Learoyd, D.L.
Erbil, M.K. see Ozcan, O. Gozansky, W.S., Lynn, J.S., Laudenslager, M.L. and Kohrt, W.M.
Ernesti, M.M. see Kinlaw, W.B. Salivary cortisol determined by enzyme immunoassay is prefer-
Erturk, K. see Ozcan, O. able to serum total cortisol for assessment of dynamic hypo-
Estepa, A. see Vilarrasa, N. thalamic—pituitary—adrenal axis activity, 336
Eunice, M. see Turton, J.P.G. Greco, E.A. see Isidori, A.M.
Evans, B.A.J. see Davies, J.H. Greenman, Y., Tordjman, K., Osher, E., Veshchey, I., Shenkerman, G.,
Evans, L.M. see Biswas, M. Reider-Groswasser, I.I., Segev, Y., Ouaknine, G. and Stern, N.
Evanson, J. see Chung, T.T. Postoperative treatment of clinically nonfunctioning pituitary
Everts, R. see Trepp, R. adenomas with dopamine agonists decreases tumour remnant
Fabbri, A. see Isidori, A.M. growth, 39
Falbo, A. see Palomba, S. Gregersen, N. see Siggaard, C.
Falorni, A. see Celi, F. Gregory, J.W. see Davies, J.H.
Feddema, P. see Walsh, J.P. Grella, E. see Rizzo, M.R.
Feelders, R.A. see van der Hoek, J. Grella, R. see Rizzo, MLR.
Feldt-Rasmussen, U. see Klose, M. Grobbee, D.E. see Lebrun, C.E.I.
Fernandez-Reyes, M.J. see Iglesias, P. Groome, N.P. see Al-Qahtani, A.
Ferone, D. see Resmini, E. Grossman, A.B. see Chung, T.T.
Ferraroni, N.R., Geloneze, B., Mansour, E., Perroud, A.P., Muscelli, Guerra, E. see Vitale, G.
E.O., Tambascia, M., de Lima Zollner, R. and Velloso, L.A. Hana, V. see Silha, J.V.
Severe hypoleptinaemia associated with insulin resistance in Handelsman, D.J. see Meier, C.
patients with common variable immunodeficiency, 63 Handelsman, D.J. see Nelson, A.E.
Ferretti, A. see Celi, F. Haq, M. and Harmer, C. Differentiated thyroid carcinoma with
Fischli, S. see Trepp, R. distant metastases at presentation: prognostic factors and
Fok, T.F. see Ng, P.C. outcome, 87
Franceschi, R. see Camilot, M. Hardin, D.S., Rice, J., Doyle, M.E. and Pavia, A. Growth hormone
Fryklund, L. see Yuen, K.C.J. improves protein catabolism and growth in prepubertal chil-
Frystyk, J. see Yuen, K.C.}. dren with HIV infection, 259
Fuller, P.J., Alexiadis, M., Jobling, T. and McNeilage, J. Seladin-1/ Hardt, J. see Kahaly, GJ.
DHCR24 expression in normal ovary, ovarian epithelial and Harmer, C. see Haq, M.
granulosa tumours, 111 Harris, P.E. see Yuen, K.C.J.
Furlan, F. see Melis, D. Harris, R.D. see Kinlaw, W.B.
Gomez, J.M. see Vilarrasa, N. Heickendorff, L. see Moosgaard, B.
Goksen, D. see Darcan, S. de Herder, W.W. see van der Hoek, J.
Gandini, A. see Camilot, M. Hindmarsh, P.C. see Mehta, A.
Gandossi, E. see Cappelli, C. Hindmarsh, P.C. see Turton, J.P.G.
Gangemi, P. see Tita, P. Hirschberg, A.L. see Berinder, K.
Gasperi, M. see Bogazzi, F. Hiura, Y. see Ueda, M.
Gatti, R. see Melis, D. Ho, K.K. see Nelson, A.E.
Geesey, M.E. see Hueston, W.J. van der Hoek, J., van der Lelij, A.-J., Feelders, R.A., de Herder, W.W.,
Geloneze, B. see Ferraroni, N.R. Uitterlinden, P., Poon, K.W., Boerlin, V., Lewis, I., Krahnke, T.,
Gennari, M. see Nicoletti, A. Hofland, L.J. and Lamberts, $.W. The somatostatin analogue
Gianfrilli, D. see Isidori, A.M. SOM230, compared with octreotide, induces differential effects
Giannetta, E. see Isidori, A.M. in several metabolic pathways in acromegalic patients, 176
Giannini, C. see Mohn, A. Hofland, L.J. see van der Hoek, J.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712
Author Index 707
Hong, A.W.L. see Thomas, G.N. Katuta, Y. see Liang, H.
Hong, S.J. see Kim, T.Y. Kaw, G.J.-L. see Leow, M.K.-S.
Howe, C.J. see Nelson, A.E. Kazlauskas, R. see Nelson, A.E.
Huang, C.-C. see Liu, R.-T. Kennedy, A. see Atkinson, A.B.
Hueston, W.J., King, D.E. and Geesey, M.E. Serum biomarkers for Kim, D.J. see Lee, S.
cardiovascular inflammation in subclinical hypothyroidism, Kim, H.Y. see Kim, S.M.
582 Kim, N.H. see Kim, S.M.
Hughes, I.A. see Deeb, A. Kim, S.C. see Kim, T.Y.
Hulting, A.-L. see Berinder, K. Kim, S.G. see Kim, S.M.
Hunt, P. see Soule, S. Kim, S.M., Lee, J., Ryu, O.H., Lee, K.W., Kim, H.Y., Seo, J.A., Kim,
Hwang, R. see Lee, S. S.G., Kim, N.H., Baik, $.H., Choi, D.S. and Choi, K.M. Serum
Idris, I., Srinivasan, R., Simm, A. and Page, R.C. Maternal hypo- osteoprotegerin levels are associated with inflammation and
thyroidism in early and late gestation: effects on neonatal and pulse wave velocity, 594
obstetric outcome, 560 Kim, S.Y. see Kim, T-Y.
Iglesias, P., Acosta, M., Sanchez, R., Fernandez-Reyes, M.J., Mon, C. Kim, T-Y., Kim, W.B., Song, J.-Y., Rhee, Y.S., Gong, G., Cho, Y.M., Kim, S.Y.,
and Diez, J.J. Ambulatory blood pressure monitoring in Kim, S.C., Hong, S.J. and Shong, Y.K. The BRAF’” mutation
patients with hyperthyroidism before and after control of thy- is not associated with poor prognostic factors in Korean patients
roid function, 66 with conventional papillary thyroid microcarcinoma, 588
Ihm, S.H. see Oh, K.W. Kim, W.B. see Kim, T.Y.
Inaba, M. see Ueda, M. King, D.E. see Hueston, W.].
Inder, W. see Soule, S. Kinlaw, W.B., Scott, S.M., Maue, R.A., Memoli, V.A., Harris, R.D.,
Ishikawa, T. see Ueda, M. Daniels, G.H., Porter, D.M., Belloni, D.R., Spooner, E.T.,
Isidori, A. see Isidori, A.M. Ernesti, M.M. and Noll, W.W. Multiple endocrine neoplasia 2A
Isidori, A.M., Giannetta, E., Gianfrilli, D., Greco, E.A., Bonifacio, V., due to a unique C609S RET mutation presents with pheochro-
Aversa, A., Isidori, A., Fabbri, A. and Lenzi, A. Effects of testoster- mocytoma and reduced penetrance of medullary thyroid car-
one on sexual function in men: results of a meta-analysis, 381 cinoma, 676
Isidori, A.M., Giannetta, E., Greco, E.A., Gianfrilli, D., Bonifacio, V., Kistorp, C. see Ogard, C.G.
Isidori, A., Lenzi, A. and Fabbri, A. Effects of testosterone on Kletter, K. see Karanikas, G.
body composition, bone metabolism and serum lipid profile in Klose, M., Lange, M., Kosteljanetz, M., Poulsgaard, L. and Feldt-
middle-aged men: a meta-analysis, 280 Rasmussen, U. Adrenocortical insufficiency after pituitary
Jadon, D. see Biswas, M. surgery: an audit of the reliability of the conventional short
Jagannathan, N.R. see Sinha, S. synacthen test, 499
Jallad, R. see Bronstein, M. Kobayashi, J. see Liang, H.
Jallad, R.S., Musolino, N.R.C., Salgado, L.R. and Bronstein, M.D. Kohrt, W.M. see Gozansky, W.S.
Treatment of acromegaly with octreotide-LAR: extensive ex- Kontur, S. see Karanikas, G.
perience in a Brazilian institution, 168 Koppeschaar, H.P.F. see Yuen, K.C.].
Jarkovska, Z. see Silha, J.V. Kosteljanetz, M. see Klose, M.
Javor, E.D. see Musso, C. Krahnke, T. see van der Hoek, J.
Jenney, M.E.M. see Davies, J.H. Krsek, M. see Silha, J.V.
Jenuso, R. see Stagi, S. Kullmann, V. see Mai, K.
Jezkova, J. see Silha, J.V. Kumar, M. see Sinha, S.
Jobling, T. see Fuller, P.J. Kumar, V. see Sinha, S.
Johns, J. see Al-Qahtani, A. Kumeda, Y. see Ueda, M.
Jones, T.H. see Kapoor, D. Kwek, D.S.-K. see Leow, M.K.-S.
de Jong, F.H. see Lebrun, C.E.I. LHermite-Balériaux, M. see Leproult, R.
Kahaly, G.J., Petrak, F., Hardt, J., Pitz, S. and Egle, U.T. Psychosocial Lam, C.W.K. see Ng, P.C.
morbidity of Graves’ orbitopathy, 395 Lam, C.W.K. see Thomas, G.N.
Kaltsas, G. see Chrousos, G.P. Lamberts, S.W. see van der Hoek, J.
Kang, M.I. see Oh, K.W. Lamberts, $.W.J. see Lebrun, C.E.I.
Kapoor, D., Malkin, C.J., Channer, K.S. and Jones, T.H. Androgens, Lambrecht, E.Y. see Darcan, $.
insulin resistance and vascular disease in men, 239 Lange, M. see Klose, M.
Karacan, I. see Aydin, T. Lapi, E. see Stagi, S.
Karanikas, G., Schuetz, M., Wahl, K., Paul, M., Kontur, S., Piet- Lapi, P. see Barbaro, D.
schmann, P., Kletter, K., Dudczak, R. and Willheim, M. Relation Lau, E. see Thomas, G.N.
of anti-TPO autoantibody titre and T-lymphocyte cytokine Laudenslager, M.L. see Gozansky, W.S.
production patterns in Hashimoto’s thyroiditis, 191 Lauri, E. see Morpurgo, P.S.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712
708 Author Index
Lavis, V.R. see Picolos, M.K. Losi, S. see Stagi, S.
Learoyd, D.L., Gosnell, J., Elston, M.S., Saurine, T.J., Richardson, A.-L., Luthra, K. see Sinha, S.
Delbridge, L.W., Conaglen, J.V. and Robinson, B.G. Experience Lynn, J.S. see Gozansky, W.S.
of prophylactic thyroidectomy in multiple endocrine neoplasia MoOhlig, M. see Mai, K.
type 2A kindreds with RET codon 804 mutations, 636 Mabuchi, H. see Liang, H.
Lebrun, C.E.I., van der Schouw, Y.T., de Jong, F.H., Pols, H.A.P., Macchia, E. see Canale, D.
Grobbee, D.E. and Lamberts, $.W.J. Endogenous oestrogens are Mai, K. see Bobbert, T.
related to cognition in healthy elderly women, 50 Mai, K., Kullmann, V., Bobbert, T., Maser-Gluth, C., Méhlig, M.,
Lee, C.H. see Ng, P.C. Bahr, V., Pfeiffer, A.R.H., Spranger, J. and Diederich, S. In vivo
Lee, J. see Kim, S.M. activity of 11B-hydroxysteroid dehydrogenase type 1 and free
Lee, J. see Lee, S. fatty acid-induced insulin resistance, 442
Lee, K.W. see Kim, S.M. Malkin, C.J. see Kapoor, D.
Lee, L.S.-U. see Leow, M.K.-S. Manguso, F. see Palomba, S.
Lee, S., Hwang, R., Lee, J., Rhee, Y., Kim, D.J., Chung, U.-I. and Lim, Manoliu, R.A. see Arwert, L.I.
S.-K. Ectopic expression of vasopressin V1b and V2 receptors Mansour, E. see Ferraroni, N.R.
in the adrenal glands of familial ACTH-independent macro- Maravall, J. see Vilarrasa, N.
nodular adrenal hyperplasia, 625 Marcovecchio, M. see Mohn, A.
Lee, W.Y. see Oh, K.W. Marek, J. see Silha, J.V.
Lee, Y.S. see Deeb, A. Martinez-Riquelme, A. see Gonzalez-Clemente, J.M.
Leedman, P.J. see Walsh, J.P. Martino, E. see Bogazzi, F.
van der Lelij, A.-J. see van der Hoek, J. Martino, E. see Canale, D.
Lenzi, A. see Isidori, A.M. Martins, I.J. see Ng, T.W.K.
Leow, M.K.-S., Kwek, D.S.-K., Ng, A.W.-K., Ong, K.-C., Kaw, G.J.-L. Marzullo, P. see Colao, A.
and Lee, L.S.-U. Hypocortisolism in survivors of severe acute Maser-Gluth, C. see Bobbert, T.
respiratory syndrome (SARS), 197 Maser-Gluth, C. see Mai, K.
Leproult, R., Van Onderbergen, A., LHermite-Balériaux, M., Van Mason, C. see Deeb, A.
Cauter, E. and Copinschi, G. Phase-shifts of 24-h rhythms of Mattanza, C. see Cappelli, C.
hormonal release and body temperature following early Maue, R.A. see Kinlaw, W.B.
evening administration of the melatonin agonist agomelatine Mauricio, D. see Gonzalez-Clemente, J.M.
in healthy older men, 298 McCance, D.R. see Atkinson, A.B.
Leselbaum, A. see Bronstein, M. McEwan, P. see Biswas, M.
Lewis, I. see van der Hoek, J. McMillan, C.V. see Razvi, S.
Li, C.-L. see Liu, R.-T. McNeilage, J. see Fuller, P.J.
Liang, H., Murase, Y., Katuta, Y., Asano, A., Kobayashi, J. and Megia, A. see Gonzalez-Clemente, J.M.
Mabuchi, H. Association of LMNA 1908C/T polymorphism Megia, A. see Vilarrasa, N.
with cerebral vascular disease and diabetic nephropathy in Mehta, A. see Turton, J.P.G.
Japanese men with type 2 diabetes, 317 Mehta, A., Hindmarsh, P.C., Stanhope, R.G., Turton, J.P.G.,
Liberati, C.D. see Canale, D. Cole, T.J., Preece, M.A. and Dattani, M.T. The role of growth
Lightman, S. see Crown, A. hormone in determining birth size and early postnatal growth,
Lim, S.-K. see Lee, S. using congenital growth hormone deficiency (GHD) as a
de Lima Zollner, R. see Ferraroni, N.R. model, 223
Lips, P. see Arwert, L.I. Meier, C., Liu, P-Y., Handelsman, D.J. and Seibel, M.J. Endocrine
I ips, P. see Puts, M.T.E. regulation of bone turnover in men, 603
Lips, P. see Schaap, L.A. Melis, D., Parenti, G., Gatti, R., Casa, R.D., Parini, R., Riva, E.,
Liu, H., Bravata, D.M., Cabaccan, J., Raff, H. and Ryzen, E. Elevated Burlina, A.B., Vici, C.D., Di Rocco, M., Furlan, FE. Torcoletti, M.,
late-night salivary cortisol levels in elderly male type 2 diabetic Papadia, F., Donati, A., Benigno, V. and Andria, G. Efficacy of
veterans, 642 ACE-inhibitor therapy on renal disease in glycogen storage dis-
Liu, PY. see Meier, C. ease type 1: a multicentre retrospective study, 19
Liu, P.Y., Wang, C. and Swerdloff, R.S. Male sex matters, 601 Melsen, F. see Moosgaard, B.
Liu, R.-T., Chen, Y.-J., Chou, E.-F., Li, C.-L., Wu, W.-L., Tsai, P.-C., Memoli, V.A. see Kinlaw, W.B.
Huang, C.-C. and Cheng, J.-T. No correlation between BRAFY Mencacci, M. see Celi, F.
mutation and clinicopathological features of papillary thyroid Meucci, G. see Barbaro, D.
carcinomas in Taiwan, 461 Michelangeli, V. see Walsh, J.P.
Locci, M.T. see Bogazzi, F. Micheletti, L. see Cappelli, C.
Lombardi, G. see Colao, A. Mielke, K.L. see Soares-Welch, C.
Lombardi, G. see Vitale, G. Milone, F. see Vitale, G.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704-712
Author Index 709
Minuto, F. see Resmini, E. Noll, W.W. see Kinlaw, W.B.
Misra, A. see Sinha, S. O'Leary, P. see Walsh, J.P.
Mohn, A., Di Marzio, D., Giannini, C., Capanna, R., Marcovecchio, M. Obach, R. see Bronstein, M.
and Chiarelli, F. Alterations in the oxidant-antioxidant status Ogard, C.G., Engelmann, M.D., Kistorp, C., Nielsen, $.L. and
in prepubertal children with growth hormone deficiency: effect Vestergaard, H. Increased plasma N-terminal pro-B-type
of growth hormone replacement therapy, 537 natriuretic peptide and markers of inflammation related to
Mon, C. see Iglesias, P. atherosclerosis in patients with primary hyperparathyroidism,
Monson, J.P. see Chung, T.T. 493
Moosgaard, B., Vestergaard, P., Heickendorff, L., Melsen, F., Oh, K.W., Lee, W.Y., Rhee, E.J., Baek, K.H., Yoon, K.H., Kang, M.L.,
Christiansen, P. and Mosekilde, L. Vitamin D status, seasonal Yun, E.J., Park, C.Y., Ihm, S.H., Choi, M.G., Yoo, H.J. and
variations, parathyroid adenoma weight and bone mineral Park, S.W. The relationship between serum resistin, leptin,
density in primary hyperparathyroidism, 506 adiponectin, ghrelin levels and bone mineral density in middle-
Morpurgo, P.S., Cappiello, V., Verga, U., Vicentini, L., Vaghi, I., Lauri, aged men, 131
E., Nebuloni, M., Beck-Peccoz, P. and Spada, A. Ghrelin in Ong, K.-C. see Leow, M.K.-S.
human medullary thyroid carcinomas, 437 Onoda, N. see Ueda, M.
Moschini, C. see Canale, D. Oostdijk, W. see Mul, D.
Mosekilde, L. see Moosgaard, B. Orio Jr, F. see Palomba, S.
Mourits, M.P. see Wakelkamp, I.M.M.]J. Orlander, P.R. see Picolos, M.K.
Mul, D., Oostdijk, W., Waelkens, J.J.J. and Drop, S.L.S. Final height Orsini, P. see Barbaro, D.
after treatment of early puberty in short adopted girls with Osher, E. see Greenman, Y.
gonadotrophin releasing hormone agonist with or without Otto, B. see Bobbert, T.
growth hormone, 185 Ouaknine, G. see Greenman, Y.
Murase, Y. see Liang, H. Ozcan, O., Cakir, E., Yaman, H., Akgul, E.O., Erturk, K., Beyhan, Z.,
Murgatroyd, P.R. see Yuen, K.C.J. Bilgi, C. and Erbil, M.K. The effects of thyroxine replacement
Murphy, L.J. see Silha, J.V. on the levels of serum asymmetric dimethylarginine (ADMA)
Muscelli, E.O. see Ferraroni, N.R. and other biochemical cardiovascular risk markers in patients
Musolino, N. see Bronstein, M. with subclinical hypothyroidism, 203
Musolino, N.R.C. see Jallad, R.S. Ozener, C. see Yavuz, D.
Musso, C., Shawker, T., Cochran, E., Javor, E.D., Young, J. and Page, R.C. see Idris, I.
Gorden, P. Clinical evidence that hyperinsulinaemia independ- Palomba, S., Orio Jr, F.,, Falbo, A., Russo, T., Caterina, G., Manguso, F,,
ent of gonadotropins stimulates ovarian growth, 73 Tolino, A., Colao, A. and Zullo, EF.M etformin administration
Muttukrishna, S. see Al-Qahtani, A. and laparoscopic ovarian drilling improve ovarian response to
Nagasaki, T. see Ueda, M. clomiphene citrate (CC) in oligo-anovulatory CC-resistant
Nebuloni, M. see Morpurgo, P.S. women with polycystic ovary syndrome, 631
Nelson, A.E., Howe, C.J., Nguyen, T.V., Seibel, M.J., Baxter, R.C., Pandey, R.M. see Sinha, S.
Handelsman, D.J., Kazlauskas, R. and Ho, K.K. Erythropoietin Panzarella, T. see Brierley, J.
administration does not influence the GH-IGF axis or makers Paolisso, G. see Rizzo, M.R.
of bone turnover in recreational athletes, 305 Papadia, F. see Melis, D.
Neri, A.S. see Stagi, S. Papi, F. see Celi, F.
Ng, A.W.-K. see Leow, M.K.-S. Parenti, G. see Melis, D.
Ng, P.C., Lee, C.H., Lam, C.W.K., Chan, I.H.S., Wong, E. and Fok, Parini, R. see Melis, D.
T.E Ghrelin in preterm and term newborns: relation to anthro- Park, C.Y. see Oh, K.W.
pometry, leptin and insulin, 217 Park, S.W. see Oh, K.W.
Ng, T.W.K., Watts, G.E, Stuckey, B.G.A., Ching, H.L., Chan, D.C.F, Pasquali, D. see De Bellis, A.
Uchida, Y., Sakai, N., Yamashita, S., Martins, I.J., Redgrave, T.G. Pasquini, C. see Barbaro, D.
and Barrett, P.H.R. Does pravastatin increase chylomicron Paul, M. see Karanikas, G.
remnant catabolism in postmenopausal women with type2 Pavia, A. see Hardin, D.S.
diabetes mellitus?, 650 Pedersen, E.B. see Siggaard, C.
Nguyen, T.V. see Nelson, A.E. Pemberton, C. see Soule, S.
Nicoletti, A., Baldazzi, L., Balsamo, A., Barp, L., Pirazzoli, P., Perrino, S. see De Bellis, A.
Gennari, M., Radetti, G., Cacciari, E. and Cicognani, A. Perroud, A.P. see Ferraroni, N.R.
SRDS5A2 gene analysis in an Italian population of under- Petrak, F. see Kahaly, G.J.
masculinized 46,XY subjects, 475 Pezzino, V. see Tita, P.
Nicoletti, G. see Rizzo, M.R. Pfeiffer, A.RH. see Bobbert, T.
Nielsen, S.L. see Ogard, C.G. Pfeiffer, A.RH. see Mai, K.
Nishizawa, Y. see Ueda, M. Picolos, M.K., Lavis, V.R. and Orlander, P.R. Milk—alkali syndrome
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712
710 Author Index
is a major cause of hypercalcaemia among non-end-stage renal Roos, J.C. see Arwert, L.I.
disease (non-ESRD) inpatients, 566 Rosei, E.A. see Cappelli, C.
Pietschmann, P. see Karanikas, G. Rosicka, M. see Silha, J.V.
Pinchera, A. see Canale, D. Russo, D. see Bogazzi, F.
Pirazzoli, P. see Nicoletti, A. Russo, T. see Palomba, S.
Pirola, I. see Cappelli, C. Ryu, O.H. see Kim, $.M.
Pitz, S. see Kahaly, G.J. Ryzen, E. see Liu, H.
Pivonello, R. see Colao, A. Saeed, P. see Wakelkamp, I.M.M.].
Pivonello, R. see Vitale, G. Sahin, Z. see Aydin, T.
Plowman, P.N. see Chung, T.T. Sakai, N. see Ng, T.W.K.
Pluijm, S.M.F. see Schaap, L.A. Salgado, L.R. see Jallad, R.S.
Pols, H.A.P. see Lebrun, C.E.I. Salti, R. see Stagi, S.
Poon, K.W. see van der Hoek, J. Sanchez, R. see Iglesias, P.
Porter, D.M. see Kinlaw, W.B. Sanderson, J.E. see Thomas, G.N.
Poulsgaard, L. see Klose, M. Santilli, E. see Celi, F.
Preece, M.A. see Mehta, A. Sardella, C. see Bogazzi, F.
Prummel, M.F. see Wakelkamp, I.M.M.]. Saurine, T.J. see Learoyd, D.L.
Puts, M.T.E., Visser, M., Twisk, J.W.R., Deeg, D.J.H. and Lips, P. Savastano, S. see Vitale, G.
Endocrine and inflammatory markers as predictors of frailty, Scanlon, M.F. see Biswas, M.
403 Schaap, L.A., Pluijm, $.M.F., Smit, J.H., van Schoor, N.M., Visser, M.,
Radetti, G. see Camilot, M. Gooren, L.J.G. and Lips, P. The association of sex hormone
Radetti, G. see Nicoletti, A. levels with poor mobility, low muscle strength and incidence
Raff, H. see Liu, H. of falls among older men and women, 152
Raggi, F. see Bogazzi, F. van der Schouw, Y.T. see Lebrun, C.E.L.
Ragno, E. see Rizzo, M.R. van Schoor, N.M. see Schaap, L.A.
Ramis, J. see Bronstein, M. Schuetz, M. see Karanikas, G.
Rapa, A. see Camilot, M. Scollo, C. see Tita, P.
Rathi, M. see Sinha, S. Scott, S.M. see Kinlaw, W.B.
Raudsepp, S. see Soule, S. Seckl, J.R. see Reynolds, R.M.
Raza, J. see Turton, J.P.G. Segev, Y. see Greenman, Y.
Razvi, S., McMillan, C.V. and Weaver, J.U. Instruments used in Seibel, M.J. see Meier, C.
measuring symptoms, health status and quality of life in Seibel, M.J. see Nelson, A.E.
hypothyroidism: a systematic qualitative review, 617 Seo, J.A. see Kim, S.M.
Redgrave, T.G. see Ng, T.W.K. Shawker, T. see Musso, C.
Rees, D.A. see Biswas, M. Shenkerman, G. see Greenman, Y.
Reider-Groswasser, I.I. see Greenman, Y. Sheridan, B. see Atkinson, A.B.
Resmini, E., Barreca, A., Ferone, D., Giusti, M., Sidoti, M. and Shong, Y.K. see Kim, T-Y.
Minuto, F. Effect of different therapeutic modalities on spon- Sidoti, M. see Resmini, E.
taneous GH secretion in acromegalic patients, 294 Siggaard, C., Christensen, J.H., Corydon, T.J., Rittig, S., Robertson,
Reynolds, R.M. and Seckl, J.R. Hyponatraemia for the clinical endo- G.L., Gregersen, N., Bolund, L. and Pedersen, E.B. Expression
crinologist, 366 of three different mutations in the arginine vasopressin gene
Rhee, E.J. see Oh, K.W. suggests genotype—phenotype correlation in familial neuro-
Rhee, Y. see Lee, S. hypophyseal diabetes insipidus kindreds, 207
Rhee, Y.S. see Kim, T.Y. Silha, J.V., Krsek, M., Hana, V., Marek, J., Weiss, V., Jezkova, J.,
Rice, J. see Hardin, D.S. Rosicka, M., Jarkovska, Z. and Murphy, L.J. The effects of
Richardson, A.-L. see Learoyd, D.L growth hormone status on circulating levels of vascular growth
Richart, C. see Gonzalez-Clemente, J.M. factors, 79
Richart, C. see Vilarrasa, N. Simon, I. see Gonzalez-Clemente, J.M.
Rittig, S. see Siggaard, C. Simon, I. see Vilarrasa, N.
Riva, E. see Melis, D. Simi, U. see Barbaro, D.
Rizzo, M.R., Paolisso, G., Grella, R., Barbieri, M., Grella, E., Ragno, Simm, A. see Idris, I.
E., Grella, R., Nicoletti, G. and D’andrea, F. Is dermolipectomy Sinha, S., Rathi, M., Misra, A., Kumar, V., Kumar, M., Jagannathan,
effective in improving insulin action and lowering inflamma- N.R., Pandey, R.M., Dwivedi, M. and Luthra, K. Subclinical
tory markers in obese women?, 253 inflammation and soleus muscle intramyocellular lipids in
Robertson, G.L. see Siggaard, C. healthy Asian Indian males, 350
Robinson, B.G. see Learoyd, D.L. Sinisi, A.A. see De Bellis, A.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712
Author Index 711
Sirikci, O. see Yavuz, D. Turton, J.P.G., Mehta, A., Raza, J., Woods, K.S., Tiulpakov, A., Cassar, J.,
Smit, J.H. see Schaap, L.A. Chong, K., Thomas, P.Q., Eunice, M., Ammini, A.C., Bouloux,
Smith, J. see Biswas, M. P.M., Starzyk, J., Hindmarsh, P.C. and Dattani, M.T. Mutations
Soares-Welch, C., Mielke, K.L., Bowers, C.Y. and Veldhuis, J.D. within the transcription factor PROP] are rare in a cohort of
Short-term testosterone supplementation does not activate GH patients with sporadic combined pituitary hormone deficiency
and IGF-I production in postmenopausal women, 32 (CPHD), 10
Soler, J. see Vilarrasa, N. Twickler, T.B. see Yuen, K.C.].
Song, J.Y. see Kim, T.Y. Twisk, J.W.R. see Arwert, LI.
Soule, S., Pemberton, C., Hunt, P., Cole, D., Raudsepp, S. and Inder, Twisk, J.W.R. see Puts, M.T.E.
W. Prandial regulation of ghrelin secretion in humans: does Uberti, E.C.D. see Tita, P.
glucagon contribute to the preprandial increase in circulating Uchida, Y. see Ng, T.W.K.
ghrelin?, 412 Ueda, M., Inaba, M., Kumeda, Y., Nagasaki, T., Hiura, Y., Tahara, H.,
Spada, A. see Morpurgo, P.S. Onoda, N., Ishikawa, T. and Nishizawa, Y. The significance of
Spooner, E.T. see Kinlaw, W.B. thyroid blood flow at the inferior thyroid artery as a predictor
Spranger, J. see Bobbert, T. for early Graves’ disease relapse, 657
Spranger, J. see Mai, K. Uitterlinden, P. see van der Hoek, J.
Srinivasan, R. see Idris, I. Ultimieri, F. see Bogazzi, F.
Stackenis, I. see Berinder, K. Unak, P. see Darcan, S.
Stagi, S., Bindi, G., Neri, A.S., Lapi, E., Losi, S., Jenuso, R., Salti, R. Undén, A.-L., Elofsson, S. and Brismar, K. Gender differences in the
and Chiarelli, F Thyroid function and morphology in patients relation of insulin-like growth factor binding protein-1 to
affected by Williams syndrome, 456 cardiovascular risk factors: a population-based study, 94
Stanhope, R.G. see Mehta, A. Vaghi, I. see Morpurgo, P.S.
Starzyk, J. see Turton, J.P.G. Van Cauter, E. see Leproult, R.
Stern, N. see Greenman, Y. Van Onderbergen, A. see Leproult, R.
Stettler, C. see Trepp, R. Veldhuis, J.D. see Soares-Welch, C.
Stuckey, B.G.A. see Ng, T.W.K. Velloso, L.A. see Ferraroni, N.R.
Swerdloff, R.S. see Liu, P-Y. Vendrell, J. see Gonzalez-Clemente, J.M.
Tahara, H. see Ueda, M. Vendrell, J. see Vilarrasa, N.
Tambascia, M. see Ferraroni, N.R. Verga, U. see Morpurgo, P.S.
Tato, L. see Camilot, M. Veshchey, I. see Greenman, Y.
Teofoli, F. see Camilot, M. Vestergaard, H. see Ogard, C.G.
Themmen, A.P.N. see Al-Qahtani, A. Vestergaard, P. see Moosgaard, B.
Thomas, G.N., Hong, A.W.L., Tomlinson, B., Lau, E., Lam, C.W.K., Vicentini, L. see Morpurgo, P.S.
Sanderson, J.E. and Woo, J. Effects of Tai Chi and resistance Vici, C.D. see Melis, D.
training on cardiovascular risk factors in elderly Chinese sub- Vigneri, R. see Tita, P.
jects: a 12-month longitudinal, randomized, controlled inter- Vilarrasa, N., Vendrell, J., Maravall, J., Broch, M., Estepa, A., Megia,
vention study, 663 A., Soler, J., Simon, I., Richart, C. and Gomez, J.M. Distribution
Thomas, P.Q. see Turton, J.P.G. and determinants of adiponectin, resistin and ghrelin in a ran-
Tironi, A. see Cappelli, C. domly selected healthy population, 329
Tita, P., Ambrosio, M.R., Scollo, C., Carta, A., Gangemi, P., Visser, J.A. see Al-Qahtani, A.
Bondanelli, M., Vigneri, R., Uberti, E.C.D. and PezzinoV, . High Visser, M. see Puts, M.T.E.
prevalence of differentiated thyroid carcinoma in acromegaly, 161 Visser, M. see Schaap, L.A.
Tiulpakov, A. see Turton, J.P.G. Vitale, G., Pivonello, R., Auriemma, R.S., Guerra, E., Milone, F.,
Tolino, A. see Palomba, S. Savastano, S., Lombardi, G. and Colao, A. Hypertension in
Tomlinson, B. see Thomas, G.N. acromegaly and in the normal population: prevalence and
Topcu, G. see Yavuz, D. determinants, 470
Torcoletti, M. see Melis, D. Waelkens, J.J.J. see Mul, D.
Tordjman, K. see Greenman, Y. Wahl, K. see Karanikas, G.
Tortora, F. see Colao, A. Wakelkamp, I.M.M.J., Baldeschi, L., Saeed, P., Mourits, M.P.,
Trepp, R., Everts, R., Stettler, C., Fischli, S., Allemann, S., Webb, S.M. Prummel, M.F. and Wiersinga, W.M. Surgical or medical
and Christ, E.R. Assessment of quality of life in patients with decompression as a first-line treatment of optic neuropathy in
uncontrolled vs. controlled acromegaly using the Acromegaly Graves’ ophthalmopathy? A randomized controlled trial, 323
Quality of Life Questionnaire (AcroQoL), 103, 238 Walker, D. see Chung, T.T.
Tsai, P.-C. see Liu, R.-T. Walsh, J.P., Bremner, A.P., Bulsara, M.K., O’leary, P., Leedman, P.J.,
Tsang, R. see Brierley, J. Feddema, P. and Michelangeli, V. Thyroid dysfunction and
Turton, J.P.G. see Mehta, A. serum lipids: a community-based study, 670
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712
712 Author Index
Wang, C. see Liu, P-Y. Yaman, H. see Ozcan, O.
Watts, G.F. see Ng, T.W.K. Yamashita, S. see Ng, T.W.K.
Weaver, J.U. see Razvi, S. Yavuz, D., Topcu, G., Ozener, C., Akalin, S. and Sirik¢i, O. Macro-
Weaver, J.U. Obesity, cytokines and the search for beauty, 251 prolactin does not contribute to elevated levels of prolactin in
Webb, S.M. see Trepp, R. patients on renal replacement therapy, 520
Weiss, V. see Silha, J.V. Yoo, H.J. see Oh, K.W.
White, D.K. see Yuen, K.C.J. Yoon, K.H. see Oh, K.W.
Wiersinga, W.M. see Wakelkamp, I.M.M.J. Young, J. see Musso, C.
Wiggam, M.I. see Atkinson, A.B. Yuen, K.C.J., Frystyk, J., White, D.K., Twickler, T.B., Koppeschaar,
Willheim, M. see Karanikas, G. H.P.F., Harris, P.E., Fryklund, L., Murgatroyd, P.R. and Dunger,
Wong, E. see Ng, P.C. D.B. Improvement in insulin sensitivity without concomitant
Woo, J. see Thomas, G.N. changes in body composition and cardiovascular risk markers
Woods, K.S. see Turton, J.P.G. following fixed administration of a very low growth hormone
Wu, W.-L. see Liu, R.-T. (GH) dose in adults with severe GH deficiency, 428
Xing, M.Z. The T1799A BRAF mutation is not a germline mutation Yun, E.J. see Oh, K.W.
in familial nonmedullary thyroid cancer, 263 Zullo, F. see Palomba, S.
Yalman, O. see Darcan, S$.
© 2005 Blackwell Publishing Ltd, Clinical Endocrinology, 63, 704—712